Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11718
Title: Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease.
Authors: Roberts, Matthew A;Velkoska, Elena;Ierino, Francesco L;Burrell, Louise M
Affiliation: Department of Nephrology, Austin Health, Melbourne, Australia
Issue Date: 27-Mar-2013
Citation: Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 2013; 28(9): 2287-94
Abstract: Angiotensin-converting enzyme 2 (ACE2) is a novel regulator of the renin-angiotensin system that counteracts the adverse effects of angiotensin II. In heart failure patients, elevated plasma ACE2 activity predicted adverse events and greater myocardial dysfunction. We aimed to describe plasma ACE2 activity and its clinical associations in patients with kidney disease.Patients recruited from a single centre comprised of chronic kidney disease Stage III/IV (CKD), haemodialysis patients and kidney transplant recipients (KTRs). Plasma ACE2 enzyme activity was measured using a fluorescent substrate assay in plasma, collected at baseline and stored at -80°C. Linear regression was performed in both males and females separately to determine the covariates associated with log-transformed ACE2.The median (interquartile range) plasma ACE2 activity in pmol/mL/min was 15.9 (8.4-26.1) in CKD (n = 59), 9.2 (3.9-18.2) in haemodialysis (n = 100) and 13.1 (5.7-21.9) in KTR (n = 80; P < 0.01). In male haemodialysis patients, ACE2 activity was 12.1 (6.8-19.6) compared with 4.4 (2.5-10.3) in females (P < 0.01). Log-transformed ACE2 plasma activity was associated with post-haemodialysis systolic blood pressure in females [β-coefficient 0.04, 95% confidence interval (95% CI) 0.01-0.06, P = 0.006]. In males, log-transformed ACE2 plasma activity was associated with B-type natriuretic peptide (β-coefficient 0.39, 95% CI 0.19-0.60, P < 0.001). Plasma ACE2 activity was not associated with mortality.Plasma ACE2 activity is reduced in haemodialysis patients compared with CKD patients, and in female haemodialysis patients compared with male. The different associations of plasma ACE2 activity between male and female haemodialysis patients indicate that the role of ACE2 in cardiovascular disease may differ by gender.
Internal ID Number: 23535224
URI: http://ahro.austin.org.au/austinjspui/handle/1/11718
DOI: 10.1093/ndt/gft038
URL: http://www.ncbi.nlm.nih.gov/pubmed/23535224
Type: Journal Article
Subjects: angiotensin-converting enzyme 2
cardiovascular disease
chronic dialysis
chronic kidney disease
end-stage kidney disease
Aged
Biological Markers.metabolism
Cohort Studies
Cross-Sectional Studies
Female
Follow-Up Studies
Humans
Kidney Transplantation
Male
Middle Aged
Peptidyl-Dipeptidase A.blood
Prognosis
Renal Dialysis
Renal Insufficiency, Chronic.blood.enzymology.pathology
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.